Jemal A, Bray F, Center M, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;(2):69–90.
2.
Atkin W, Edwards R, Kralj-Hans I, Wooldrage K, Hart A, Northover J. UK Flexible Sigmoidoscopy Trial Investigators.Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet. 2010;(9726):1624–33.
3.
Mihajlovi J, Pechlivanoglou P, Miladinov-Mikov M, Ivkovi S, Postma M. Cancer incidence and mortality in Serbia. BMC Cancer. 1999;(1):18.
4.
Muto T, Bussey H, Morison B. The evolution of cancer of the colon and rectum. Cancer. 1975;2251–70.
5.
Winawer S, Zauber A, Ho M. Prevention of Colorectal Cancer by colonoscopic Polypectomy. N Engl J Med. 1993;1977–81.
6.
O’connell J, Maggard M, Ko C. Colon cancer survival rates with the new American Joint Committe on Cancer six edition staging. J Natl Cancer Inst. 2004;1420–5.
7.
Wilson J, Junger G. Principles and Practice of Screening for Disease. 1968;
8.
Bretthauer M. Evidence for colorectal cancer screening. Best Pract Res Clin Gastroenterol. 2010;(4):417–25.
9.
Popović Đ. Metode skriniga za kolorektalni karcinom. Završi rad akademske specijalizacije. Medicinski fakultet u Beogradu. 2007;
10.
Lee C, Ronan L, ’morain O, Mcnamara C, D. Screening for colorectal cancer: what fits best? Expert Rev Gastroenterol Hepatol. 2012;(3):301–12.
11.
Levin B, Lieberman D, Mcfarland B. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps,2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin. 2008;(3):130–60.
12.
Popović Đ, Jovanovic I, Kisić-Tepavčević D, Kovačević N. Kvalitet života pacijenata sa koloretalnim karcinomom. Arch Gastroenterohepatol. 2012;(4):17–22.
13.
Zavoral M, Suchanek S, Zavada F. Colorectal cancer screening in Europe. World J Gastroenterol. 2009;(47):5907–15.
14.
Colon A. Cancer Screenin Guidelines 2005: The Fecal Occult Blood Test Option Has Become a Better FIT. Gastroenterology. 2005;745–8.
15.
Mandel J, Bond J, Church. Reducing mortality from colorectal cancer by screening for fecal occult blood test: Minesota Colon Cancer Control Study. N Engl J Med. 1993;1365–71.
16.
Kronborg O, Fenger C, Olsen J. Randomised controlled trial of screening for colorectal cancer with faecal-occult blood. Lancet. 1996;1467–71.
17.
Asge Guideline. Colorectal cancer screening and surveillance. Gastrointest Endosc. 2006;546–57.
18.
Rex K, Johnson D, Anderson J. American College of Gastroenterology Guidelines for Colorectal Cancer Screening. Am J Gastroenterol. 2008;739–50.
19.
Lieberman D, Weiss, Bond J. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. N Engl J Med. 2000;162–8.
20.
Atkin W, Cuzick J, Northover J. Prevention of colorectal cancer by once-only sigmoidoscopy. Lancet. 1993;736–40.
21.
Lieberman D, Weiss D. One time screening for colorectal cancer with combined fecal-occult blood testing and examination of the distal colon. N Engl J Med. 2001;555–60.
22.
Thils-Evensen E, Hoff G, Sauer J, Langmark F. Poplation-based surveillance by colonoscopy: effect on the incidence of colorectal cancer. Scand J Gastroenterol. 1999;414–20.
23.
Lin O, Gerson L, Soon M. Risk of proximal colon neoplasia with distal hyperplastic polyps: a meta-analysis. Arch Intern Med. 2005;382–90.
24.
Hyman N, Anderson P, Blasyk H. Hyperplastic polyposis and the risk of colorectal cancer. Dis Colon Rectum. 2004;2101–4.
25.
Alempijević T, Milutinović A, Marković A. Frequency and clinical caracteristics of colorectal adenoma and carcinoma in women. Acta Chir Iugosl. 2011;(4):51–4.
26.
Van Gossum A. Guidelines for colorectal cancer screening--a puzzle of tests and strategies. Acta Clin Belg. 2010;(6):433–6.
27.
Seitz U, Bohnacker S, Seewald S. Long therm results of endoscopic removal of large colorectal adenomas. Endoscopy. 2003;41–4.
28.
Winawer S, Stewart, Zauber A. A comparison of colonoscopy and double-contrast barium enema for surveillance after polypectomy. N Engl J Med. 2000;1766–72.
29.
Opletal P, Standara M.
30.
Klin Onkol. 2012;(4):241–5.
31.
Macari M, Bini E, Jacobs S. Colorectal polyps and cancers in asymptomatic average-risk patients: evaluation with CT colography. Radiology. 2004;629–36.
32.
Pickhardt P, Hassan C, Halligan S, Marmo R. Colorectal cancer: CT colonography and colonoscopy for detection--systematic review and meta-analysis. Radiology. 2011;(2):393–405.
33.
Rockey D, Paulson E, Niedzwiecki D. Analysis of air contrast barium enema, computed tomographic colonography and colonoscopy: prospective comparasion. Lancet. 2005;305–11.
34.
Javeri K, Williams T, Bonnett J. An overview of the method, application, and various findings of computed tomographic colonography in patients after incomplete colonoscopy. Curr Probl Diagn Radiol. 2010;(6):262–74.
35.
Berger B, Ahlquist D. Stool DNA screening for colorectal neoplasia: biological and technical basis for high detection rates. Pathology. 2012;(2):80–8.
36.
Lengauer C, Kinzler K, Vogelstein B. Genetic instability in colorectal cancer. Nature. 1997;623–7.
37.
Imperiale T, Ranshoff D, Itzkowitz S. Colorectal Cancer Study Group: fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med. 2004;2704–14.
38.
Koornstra J, De Jong S, Hollema H. Changes in apoptosis during the development of colorectal cancer: a systemical review of literature. Crit Rev Oncol Hematol. 2003;37–53.
39.
Tagore K, Lawson M, Yucaitis J. Autor za korespodenciju: Dr Dušan Đ. Popović, Klinički centar Srbije, Klinika za gastroenterologiju i hepatologiju, Pasterova 2 (Urgentni centar). Clin Colorectal Cancer. 2003;366–90.
Citation
Copyright
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.